Skip to content
HTFL·Nasdaq·US

Heartflow

Heartflow is a commercial-stage medical technology company that provides AI-enabled software for non-invasive coronary artery disease diagnosis and management. It monetizes its Heartflow FFR-CT Analysis and Plaque Analysis products primarily on a usage-based, pay-per-click model when physicians order and review the analyses.

Thematic Position

HTFL

Relationship Groups

Competitors2

Relationship details are part of the Pro plan.

Ended Relationships

3 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

intellectual propertylicensing restriction
Open-source license terms impose unanticipated restrictions on Heartflow product commercialization
SEC 10-KMar 18, 2026

The full regulatory passage is part of the Pro plan.

17 more · Regulatory and geopolitical insights are part of the Pro plan.